We are incredibly grateful for the opportunity to contribute to this significant discussion on the future of health diagnostics through oculomics, as featured in a recent publication called “Is early diagnosis always better” by The College of Optometrists.
"We like to think we’re the optometrist's best friend, as RetinaLyze will support decision-making and, in many cases, identify early signs of eye disease before the human eye can," says Chris Flynn, RetinaLyze’s UK Lead.
Prof. Alastair Denniston adds, "The power of oculomics is that we can look into your eye and see signals of your present and future health."
Are you interested in how RetinaLyze can benefit your practice? Contact us for more information or to sign up for a free trial!
